Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-16-037511
Filing Date
2016-08-15
Accepted
2016-08-15 17:27:39
Documents
31
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cenb20160630_10q.htm 10-Q 513231
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 15550
3 EXHIBIT 32.1 ex32-1.htm EX-32.1 7700
  Complete submission text file 0001437749-16-037511.txt   1468903

Data Files

Seq Description Document Type Size
4 EXHIBIT 101.INS cenb-20160630.xml EX-101.INS 117007
5 EXHIBIT 101.SCH cenb-20160630.xsd EX-101.SCH 17349
6 EXHIBIT 101.CAL cenb-20160630_cal.xml EX-101.CAL 17236
7 EXHIBIT 101.DEF cenb-20160630_def.xml EX-101.DEF 123239
8 EXHIBIT 101.LAB cenb-20160630_lab.xml EX-101.LAB 102209
9 EXHIBIT 101.PRE cenb-20160630_pre.xml EX-101.PRE 129514
Mailing Address 20 N REAR RD LAKESHORE A6 N0R 1A0
Business Address 20 N REAR RD LAKESHORE A6 N0R 1A0 226-344-0660
CEN BIOTECH INC (Filer) CIK: 0001653821 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55557 | Film No.: 161834104
SIC: 2834 Pharmaceutical Preparations